BS - Bone, Cartilage, Molecular Biology, &c Flashcards
Signal through tyrosine kinase receptors
Fibroblast growth factors, insulin-like growth factors, and platelet-derived growth factors
Parathyroid hormone receptor SIGNALLING MECHANISM
adenylyl cyclase/G-alpha stimulatory protein/cAMP/protein kinase A
TGF-ß SIGNALLING AND EFFECT osteoblasts
stimulates osteoblasts to synthesize collagen and primarily signal through serine/threonine kinase receptors
BMP SIGNALLING MECHANISM
BMPs target undifferentiated mesenchymal cells and signal through serine/threonine kinase receptors
SMADS are primary intracellular signaling mediator for bone morphogenetic protein
IGF-II SIGNALLING MECHANISM
tyrosine kinase receptors
Osteoclast ACTIVATING MOLECULES (7)
RANKL, PTH, IL1, 1,25 Vitamin D
prostaglandin E2, IL-6, MIP-1A
Osteoclast INHIBITING MOLECULES (6)
OPG, calcitonin (osteoclast receptor), estrogen, TGFbeta, IL-10
DENOSUMAB (monoclonal ab binds to RANKL like OPG)
Type 1 collagen breakdown marker
hydroxy-proline
BMP3 features (3)
Antagonizes BMP2
Most abundant BMP in demineralized bone matrix
increases chondrogenic markers
Factor that couples bone resorption and formation
TGFß
- signals osteoblasts to make bone
- acid pH activates TGFß family
- negative effect on epithelial cell proliferation
TGFß signalling pathway
Type I/II receptor –> SMAD4
- SMURFS regulate and breakdown SMADs
TGFß effects on cartilage
chondrocyte hypertrophy
(TGFß knockout mice –> arthritis)
Name 2 adhesive proteins and their function
Fibronectin - osteoblast adhesion to bone and survival
Vitronectin - osteoclast adhesion to bone (alpha-v/neta-3 integrin receptor)
Osteoblast markers (5)
osteocalcin (most specific)
alk phos
PTH receptor
osteonectin
osteopontin
osteoclast markers (4)
TRAP (tartrate resistant acid phosphatase)
calcitonin receptor
RANK
alpha-v/beta-e integrin receptor
LRP5 signalling pathway and effects
Wnt/Frizzled transduction pathway
regulates osteoblast activity
Loss function = poor bone mass “osteoporosis-pseudoglioma”
Gain function - very high boner mass
osteoporosis features (3)
- T score < 2.5 std dev (below peak bone mass)
- normal mineralization
- abnormal microarchitecture (anisotropy increased, porosity increased)
Contraindications PTH therapy (4)
- Paget’s/post irradiation (risk for osteosarc)
- open physes
- hyperparathyroidism
- metastatic bone disease
Trabecular bone features (3)
- maximum thickness plates and rods 200 micron
- blood supply = diffusion
- 30-90% porosity
Hydroxyapatite molecular formula
Ca10(PO4)6(OH)2

- Stone man syndrome, aka “fibrodysplasia ossificans progressiva”
- activating mutation in ACVR1 (BMP receptor)
Schwartzman’s reaction
systemic response to bacterial endotoxins –> DIC, fat embolism, thrombosis
May cause OSTEONECROSIS
Names and mechanism of nitrogen containing bisphosphonates
alendronate, risedronate, pamidronate, zolendronate
- inhibit mevalonate (cholesterol pathway)
- inhibits osteoclast farnesyl pyrophosphate synthase enzyme
-prevent post-translational prenylation of GTP-binding proteins
- inhibits ruffled border and microtubules
Names and mechanism of NON-nitrogen containing bisphosphonates
tiludronate, clodronate, etidronate
- produce toxic analogs of ATP



